{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:42:48Z","timestamp":1789605768726,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.metop.2026.100448","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:20:19Z","timestamp":1769818819000},"page":"100448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["COVID-19 and metabolic health: Lessons from a global pandemic"],"prefix":"10.1016","volume":"29","author":[{"given":"Maria","family":"Dalamaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Karampela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.metop.2026.100448_bib1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s13679-021-00436-y","article-title":"Understanding the Co-Epidemic of obesity and COVID-19: current evidence, comparison with previous epidemics, mechanisms, and preventive and therapeutic perspectives","volume":"10","author":"Dalamaga","year":"2021","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.metop.2026.100448_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154894","article-title":"Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity","volume":"128","author":"Kim","year":"2022","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.metop.2026.100448_bib3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S2213-8587(23)00154-7","article-title":"Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases","volume":"11","author":"Perakakis","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.metop.2026.100448_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110508","article-title":"Limited extent and consequences of pancreatic SARS-CoV-2 infection","volume":"38","author":"van der Heide","year":"2022","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.metop.2026.100448_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/endrev\/bnad032","article-title":"Diabetes mellitus, energy metabolism, and COVID-19","volume":"45","author":"Conte","year":"2024","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.metop.2026.100448_bib6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41366-021-00804-7","article-title":"Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics","volume":"45","author":"Batabyal","year":"2021","journal-title":"Int J Obes"},{"key":"10.1016\/j.metop.2026.100448_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155236","article-title":"SARS-CoV-2 infection impairs the insulin\/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1","volume":"133","author":"Shin","year":"2022","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.metop.2026.100448_bib8","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S2213-8587(21)00244-8","article-title":"COVID-19 and metabolic disease: mechanisms and clinical management","volume":"9","author":"Steenblock","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"13","key":"10.1016\/j.metop.2026.100448_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310458","article-title":"Laboratory findings and biomarkers in long COVID: what do we know So far? Insights into epidemiology, pathogenesis, therapeutic perspectives and challenges","volume":"24","author":"Tsilingiris","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.metop.2026.100448_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302977","article-title":"Metabolic profiling during COVID-19 infection in humans: identification of potential biomarkers for occurrence, severity and outcomes using machine learning","volume":"19","author":"Elgedawy","year":"2024","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.metop.2026.100448_bib11","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp2021264","article-title":"Covid-19 and disparities in nutrition and obesity","volume":"383","author":"Belanger","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metop.2026.100448_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2022.100163","article-title":"SARS-CoV-2 adipose tissue infection and hyperglycemia: a further step towards the understanding of severe COVID-19","volume":"13","author":"Tsilingiris","year":"2022","journal-title":"Metabol Open"},{"key":"10.1016\/j.metop.2026.100448_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100122","article-title":"Diabetes and COVID-19: mechanism of pneumonia, treatment strategy and vaccine","volume":"11","author":"Abbasi","year":"2021","journal-title":"Metabol Open"},{"key":"10.1016\/j.metop.2026.100448_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2020.100057","article-title":"The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: a population-based study","volume":"8","author":"Ghoneim","year":"2020","journal-title":"Metabol Open"},{"key":"10.1016\/j.metop.2026.100448_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100121","article-title":"Drug repurposing in COVID-19: a review with past, present and future","volume":"12","author":"Srivastava","year":"2021","journal-title":"Metabol Open"},{"key":"10.1016\/j.metop.2026.100448_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100137","article-title":"A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19","volume":"12","author":"Kifle","year":"2021","journal-title":"Metabol Open"},{"key":"10.1016\/j.metop.2026.100448_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.784459","article-title":"Diabetes, metformin and the clinical course of Covid-19: outcomes, mechanisms and suggestions on the therapeutic use of metformin","volume":"13","author":"Bailey","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metop.2026.100448_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100134","article-title":"SARS-CoV-2 and diabetes: a potential therapeutic effect of dipeptidyl peptidase 4 inhibitors in diabetic patients diagnosed with COVID-19","volume":"12","author":"Kifle","year":"2021","journal-title":"Metabol Open"},{"issue":"16","key":"10.1016\/j.metop.2026.100448_bib19","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.3390\/jcm14165815","article-title":"Association of dipeptidyl Peptidase-4 inhibitor use with COVID-19 mortality in diabetic patients: a nationwide cohort study in Korea","volume":"14","author":"Park","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.metop.2026.100448_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2020.100066","article-title":"The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19","volume":"8","author":"Kritis","year":"2020","journal-title":"Metabol Open"},{"issue":"3","key":"10.1016\/j.metop.2026.100448_bib21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/ptr.7724","article-title":"Curcumin for the treatment of COVID-19 patients: a meta-analysis of randomized controlled trials","volume":"37","author":"Shafiee","year":"2023","journal-title":"Phytother Res"},{"issue":"2","key":"10.1016\/j.metop.2026.100448_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/nu14020256","article-title":"Effectiveness of curcumin on outcomes of hospitalized COVID-19 patients: a systematic review of clinical trials","volume":"14","author":"Vahedian-Azimi","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.metop.2026.100448_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2026.100446","article-title":"Adherence to the mediterranean diet, particularly olive oil intake, and metabolic health parameters are independently associated with SARS-CoV-2 vaccine-induced IgG responses","volume":"29","author":"Petropoulou","year":"2026","journal-title":"Metabol Open"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936826000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936826000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T18:02:29Z","timestamp":1775757749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589936826000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":23,"alternative-id":["S2589936826000071"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2026.100448","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and metabolic health: Lessons from a global pandemic","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2026.100448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100448"}}